Trexquant Investment LP

Position in ASND — Ascendis Pharma A/S

CIK 1633445 STAMFORD, CT

Position in ASND

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$12,607,587

-$2,378,116 QoQ

Shares Held

47,269

-27.9% QoQ

Ownership

0.072%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#87

of 308 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $587,455,425 across 144 Biotechnology names. ASND ranks #11 (2.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	505,160	$35,376,354
2	REGN	Regeneron Pharmaceuticals, Inc.	41,839	$26,088,290
3	RVMD	Revolution Medicines, Inc.	120,122	$22,496,448
4	AXSM	Axsome Therapeutics, Inc.	83,679	$20,482,108
5	RARE	Ultragenyx Pharmaceutical Inc.	556,385	$18,577,695
6	INSM	INSMED Inc	156,553	$16,691,680
7	SRRK	Scholar Rock Holding Corp	275,712	$15,164,160
8	EXEL	Exelixis, Inc.	275,209	$14,974,121

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,607,587	47,269	-27.9%	Shares	Sole	2026-08-14
2026-03-31	$14,985,703	65,517	+11.0%	Shares	Sole	2026-05-15
2025-12-31	$12,586,491	59,025	+114.0%	Shares	Sole	2026-02-17
2025-09-30	$5,484,173	27,585	-57.0%	Shares	Sole	2025-11-14
2025-06-30	$11,069,701	64,135	+46.6%	Shares	Sole	2025-08-12
2025-03-31	$6,820,433	43,760	+61.7%	Shares	Sole	2025-05-14
2024-12-31	$3,726,313	27,067	+235.9%	Shares	Sole	2025-02-12
2024-09-30	$1,202,990	8,057	-66.0%	Shares	Sole	2024-11-12
2024-06-30	$3,231,796	23,697	+16.8%	Shares	Sole	2024-08-13
2024-03-31	$3,067,088	20,289	+105.6%	Shares	Sole	2024-05-14
2023-12-31	$1,242,874	9,868	+381.4%	Shares	Sole	2024-02-09
2022-12-31	$250,366	2,050	+0.4%	Shares	Sole	2023-02-13
2021-06-30	$268,625	2,042	-45.6%	Shares	Sole	2021-08-12
2020-12-31	$625,925	3,753	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.